Sleep apnea treatment may cut heart ablation need in AFib patients
NCT ID NCT04606693
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at whether screening for and treating sleep apnea can reduce the burden of atrial fibrillation (AFib) in patients who are candidates for heart ablation. Fifty adults with paroxysmal or persistent AFib that hasn't responded to medication will be screened for sleep apnea. Those diagnosed will receive standard treatment (like CPAP or lifestyle changes) and be monitored for three months. The goal is to see if their AFib improves enough to avoid the need for ablation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CPAP and lifestyle measures for sleep apnea
What this could lead to
If successful, this could show that treating sleep apnea helps control atrial fibrillation, potentially reducing the need for heart ablation in some patients.
What could go wrong
This is a small, non-randomized study with only 50 participants, so results may not apply broadly. It is also early-stage and observational, so it cannot prove cause and effect.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION, PERSISTENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Clínico San Carlos
RECRUITINGMadrid, Madrid, 28040, Spain
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact